TREATMENT OF DIABETIC KETOACIDOSIS UNDER CONTROL OF BLOOD GASES AND ACID-BASE BALANCE
DOI:
https://doi.org/10.11603/2415-8798.2018.4.9795Keywords:
diabetes mellitus, treatment of ketoacidosis, blood gas composition, acid-base balance, antihypoxantsAbstract
Determination of gas composition in arterial blood is an obligatory method of a laboratory research of patients, according to protocols of treatment of diabetic ketoacidosis. On their dynamic changes it is possible to estimate efficiency of treatment quicker. Use of antihypoxants in complex treatment of metabolic encephalopathies is estimated by experts at various critical pathological conditions.
The aim of the study – to learn studying of gas exchange violations at diabetic ketoacidosis and their dynamics in the course of treatment, with and without application of antihypoxants.
Materials and Methods. Among 55 patients with diabetic ketoacidosis aged from 9 to 65 years (the average age of the patients was (31.58±17.18) years), 38 people were selected, who simultaneously determined the gas composition of venous and arterial blood with Easy Blood Gas (USA, 2008) upon admission and through the day of the pathogenetic treatment. One group of 19 people (Group A) received basic pathogenetic therapy, the other (Group B with clinically pronounced suppression of the nervous system) – additionally intravenous drip of deproteinized hemoderivate from the blood of calves or succinic acid solution in combination with vitamins.
Results and Discussion. Indicators of venous blood at admission: oxygen tension 29.00 mm Hg in group A, 45 mm Hg in Group B, the carbon dioxide voltage is 30.80 mm Hg in Group A, 26.10 mm Hg in – in Group B, the total carbon dioxide content is 13.00 mmol / l in Group A, 8.20 mmol / l in Group B. These indicators were statistically significantly different (p <0.05). Indicators of acid-base balance, in turn, with effectively statistically insignificant difference in blood pH between the groups differed statistically significantly in the level of blood bicarbonate and standard bicarbonate. The median of these parameters, respectively, was 4.10 mmol / l; 12.85 mmol / l in Group A, 7.30 mmol / l; 7.30 mmol / l in Group B. Also differed were groups of patients with statistically significant difference (p <0.05) by respiratory coefficient (Me = 2.73: 1.50; 5.07 in Group A, Me = 1.65: 1.02; 2.34 in Group B). But arterial blood counts at admission differed in groups only by respiratory coefficient (Me = 0.06: 0.03; 0.11 in Group A, Me = 0.31: 0.08; 1.27 in Group B). A day after the treatment, the composition of arterial blood was not statistically significantly different in the Groups. But in the venous blood was statistically significantly different (p <0.05) in terms of the following parameters: oxygen tension in mm Hg (Me = 30.00: 21.00; 47.00 in Group A, Me = 43.00: 36.00; 55.00 in Group B), the voltage of carbon dioxide in mm Hg (Me = 37.20: 31.80; 47.30 in Group A,
Me = 30.30: 25.40; 36.80 in Group B), the total oxygen content in mg / dL (Me = 11.20: 5.80; 16.30 in Group A, Me = 16.60: 14.10; 18.10 in Group B).
Conclusions. The inclusion of antihypoxants to the complex treatment of diabetic ketoacidosis influenced to a large extent the indicators of gas exchange disorders of venous blood. Considering the above results of the study of blood gases, the effect of antihypoxants was based on the effect on dissolved forms of oxygen and carbon dioxide, without affecting the gaseous fractions of these gases, the level of which depends more on ventilation and blood circulation. Obviously, there was an improvement in the absorption of oxygen by the tissues against the background of the therapy of the critical state and the rapid compensation of acid-base balance, a more rapid elimination of acidosis compared with the compensation of tissue hypoxia against the background of blood hyperoxia.
References
Dedov, I.I., Shestakova, M.V., Mayorov, A.Yu., Vikulova, O.K., Galstyan, G.R., Kuraeva, T.L., ... & Suhareva, O.Yu. (2017). Algoritmy spetsializirovannoy meditsinskoy pomoshchi bolnym sakharnym diabetom [Algorithms for specialized medical care for patients with diabetes]. Sakharnyi diabet – Diabetes, 1S [in Russian].
Zaharov, V.V., & Sosina, V.B. (2010). Vozmozhnosti antigipoksantov v lechenii umerennykh kognitivnykh narusheniy u bolnykh sakharnym diabetom [Possibilities of antihypoxic drugs in the treatment of moderate cognitive impairment in patients with diabetes mellitus]. Lechaschiy vrach – The attending physician, (3), 87-91 [in Russian].
Zelinska, N.B. (2016). Diabetychnyi ketoatsydoz [Diabetic ketoacidosis]. Ukrainskyi zhurnal dytiachoi endokrynolohii – Ukrainian Journal of Pediatric Endocrinology, 3, 71-75 [in Ukrainian].
Markevich, P.S., Danilenko, S.V., & Yankin, A.V. (2010). Rol preparata “Tsitoflavin” v klinicheskoy praktike [The role of the drug “Cytoflavin” in clinical practice]. Acta Biomedica Scientifica, 3, 109-113 [in Russian].
Piradov, M.A., Tanashyan, M.M., Domashenko, M.A., Sergeev, D.V., & Maksimova, M.Yu. (2015). Neyroprotektsiya pri tserebrovaskulyarnykh zabolevaniyah: poisk zhizni na Marse ili perspektivnoe napravlenie lecheniya? Chast 1. Ostryie narusheniya mozgovogo krovoobrascheniya [Neuroprotection in cerebrovascular diseases: a search for life on Mars or a promising direction of treatment? Part 1. Acute disorders of cerebral circulation]. Annaly klinicheskoy i eksperimentalnoy nevrologii – Annals of Clinical and Experimental Neurology, 9 (1) [in Russian].
Pshenisnov, K.V., & Aleksandrovich, Yu.S. (2014). Primenenie rastvorov suktsinata v kompleksnoy intensivnoy terapii diabeticheskogo ketoatsidoza u detey (sluchay iz praktiki) [Application of solutions of succinate in complex intensive therapy of diabetic ketoacidosis for children (case for practice]. Neotlozhnaya meditsina – Emergency Medicine, 2, 32-36 [in Russian].
Sedinkin, V.A., Kligunenko, E.N. (2006). Neyroprotektsiya v intensivnoy terapii diabeticheskogo ketoatsidoza [Neuroprotection in the intensive care of diabetic ketoacidosis]. Meditsina neotlozhnyih sostoyaniy – Emergency Medicine, 5, 4, 89-95 [in Russian].
Usenko, L.V., & Tsarev, A.V. (2016). Sovremennyie vozmozhnosti energoprotektsii pri kriticheskih sostoyaniyah [Current energy protection opportunities in critical conditions]. Meditsina neotlozhnyih sostoyaniy – Emergency Medicine, 4 (75) [in Russian].
Shishkova, V.N. (2007). Perspektivy primeneniya preparata Aktovegin u patsientov s metabolicheskim sindromom i prediabetom. Sovremennyie predstavleniya o narusheniyah uglevodnogo obmena [Prospects for the use of the drug Actovegin in patients with metabolic syndrome and prediabetes. Modern concepts of carbohydrate metabolism disorders]. RMZh – RMJ, 15 (27), 2066 [in Russian].
Barone, B., Rodacki, M., Cenci, M.C.P., Zajdenverg, L., Milech, A., & Oliveira, J.E.P.D. (2007). Diabetic ketoacidosis in adults: update of an old complication.
Bilan, N., Behbahan, A.G., & Khosroshahi, A.J. (2008). Validity of venous blood gas analysis for diagnosis of acid-base imbalance in children admitted to pediatric intensive care unit. World Journal of Pediatrics, 4 (2), 114-117.
Desai, D., Mehta, D., Mathias, P., Menon, G., & Schubart, U.K. (2018). “Health Care Utilization and Burden of Diabetic Ketoacidosis in the US Over the Past Decade: A Nationwide Analysis”. Diabetes care, dc171379 URL: https://doi.org/10.2337/dc17-1379
Edge, J.A., Jakes, R.W., Roy, Y., Hawkins, M., Winter, D., Ford-Adams, M. E., ... & Dunger, D.B. (2006). The UK case–control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia, 49 (9), 2002-2009.
Glaser, N., Barnett, P., McCaslin, I., Nelson, D., Trainor, J., Louie, J., ... & Kuppermann, N. (2001). Risk factors for cerebral edema in children with diabetic ketoacidosis. New England Journal of Medicine, 344 (4), 264-269.
Herrington, W.G., Nye, H.J., Hammersley, M.S., & Watkinson, P.J. (2012). Are arterial and venous samples clinically equivalent for the estimation of pH, serum bicarbonate and potassium concentration in critically ill patients? Diabetic Medicine, 29 (1), 32-35. DOI:10,1111 / j.1464-5491.2011.03390.x
Hsia, D.S., Tarai, S.G., Alimi, A., Coss‐Bu, J.A., & Haymond, M.W. (2015). Fluid management in pediatric patients with DKA and rates of suspected clinical cerebral edema. Pediatric diabetes, 16 (5), 338-344. DOI:10,1111 / pedi.12268
Kuppermann, N., Ghetti, S., Schunk, J.E., Stoner, M.J., Rewers, A., McManemy, J.K., ... & Quayle, K.S. (2018). Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis. New England Journal of Medicine, 378 (24), 2275-2287.
Mohammed, H.M., & Abdelatief, D.A. (2016). Easy blood gas analysis: Implications for nursing. Egyptian Journal of Chest Diseases and Tuberculosis, 65 (1), 369-376.
Mohan, N., & Karunanithi, K. (2015). Can Venous Blood Gases Replace Arterial Blood Gases in Diabetic Ketoacidosis/Renal Failure Induced Metabolic Acidosis?. Universal Journal of Medical Science, 3 (3), 65-69.
Nyenwe, E.A., & Kitabchi, A.E. (2016). The evolution of diabetic ketoacidosis: an update of its etiology, pathogenesis and management. Metabolism, 65 (4), 507-521.
Regmi, A., Konstantinov, N.K., Agaba, E.I., Rohrscheib, M., Dorin, R.I., & Tzamaloukas, A.H. (2014). Respiratory failure in the course of treatment of diabetic ketoacidosis. Clinical Diabetes, 32 (1), 28-31.
Skitch, S.A., & Valani, R. (2015). Treatment of pediatric diabetic ketoacidosis in Canada: a review of treatment protocols from Canadian pediatric emergency departments. Canadian Journal of Emergency Medicine, 17 (6), 656-661.
Taghizadieh, A., Pouraghaei, M., Moharamzadeh, P., Ala, A., Rahmani, F., & Sofiani, K.B. (2016). Comparison of end-tidal carbon dioxide and arterial blood bicarbonate levels in patients with metabolic acidosis referred to emergency medicine. Journal of cardiovascular and thoracic research, 8 (3), 98.
Verma, A.K., & Roach, P. (2010). The interpretation of arterial blood gases. Aust Prescr, 33 (4), 124-129.
Watts, W., & Edge, J. A. (2014). How can cerebral edema during treatment of diabetic ketoacidosis be avoided?. Pediatric diabetes, 15(4), 271-276.
White, P. C., & Dickson, B. A. (2013). Low morbidity and mortality in children with diabetic ketoacidosis treated with isotonic fluids. The Journal of pediatrics, 163(3), 761-766. DOI: 10,1016 / j.jpeds.2013.02.005
Wolfsdorf, J., Craig, M. E., Daneman, D., Dunger, D., Edge, J., Lee, W., ... & Hanas, R. (2009). Diabetic ketoacidosis in children and adolescents with diabetes. Pediatric diabetes, 10, 118-133. DOI: 10.1111/j.1399-5448.2009.00569.x
Downloads
Published
Issue
Section
License
Authors who sent their manuscript to "Вісник наукових досліджень. Bulletin of Scientific Research" Surgery agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
